Schedule 13G Filing by YA II PN, Ltd. for RedHill Biopharma Ltd.

YA II PN, Ltd. has filed a Schedule 13G, reporting beneficial ownership of 508,723 American Depositary Shares (ADSs) of RedHill Biopharma Ltd. as of December 19, 2025. This represents 9.9% of the outstanding ADSs. The filing was made pursuant to a Standby Equity Distribution Agreement (SEPA) entered into on the same date. YA II PN, Ltd. also received a warrant to purchase an additional 590,446 ADSs. The agreement prohibits YA II PN, Ltd. and its affiliates from acquiring ADSs that would result in beneficial ownership exceeding 9.99% of the outstanding ADSs. The ownership calculation is based on 5,092,326 ADSs outstanding, including those received by YA II PN, Ltd. under the SEPA. Several entities and individuals, including YA Global Investments II (U.S.), LP, Yorkville Advisors Global, LP, Yorkville Advisors Global II, LLC, YAII GP, LP, YAII GP II, LLC, SC-Sigma Global Partners, LP, and Mark Angelo, are identified as affiliates who may be deemed to beneficially own the same number of ADSs.